Patent · US Active

Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

US7935713B2 · kind B2 · utility

1Cited by

6References

14Claims

0Family size

Assignee

Merck Sharp & Dohme LLC · US

Inventors

Ronald Kim · Essen, DE
Emma R. Parmee · Scotch Plains, US
Qiang Tan · Westfield, US
Cangming Yang · South River, US
Ashley Rouse Lins · Edison, US

Key dates

Filing date	May 11, 2007
Grant date	May 3, 2011
Priority date	—
Expiry date	Mar 2, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.